Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Leiomyoma × telapristone acetate × Clear all

Phase

Phase 2 10 Phase 3 5 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myofibroma 1 Leiomyoma 1

Interventions

telapristone acetate 1 cetrorelix 1 Triptorelin Pamoate 1 Menotropins 1 Leuprolide 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Gonadotropins 1 Chorionic Gonadotropin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01069094 2014-06-30

A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata

Repros Therapeutics Inc.

Phase 1/2 Completed

Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡